This is not just another tool to image cancer. The probe is a two-for-one: detect cancer and distinguish one type from another. Together, they develop a cancer fingerprint.
Determining the presence of cancer, as well as its type and malignancy, is a stressful process for patients that can take up to two weeks to get a diagnosis. With a new bit of technology—a sugar-transporting biosensor—researchers at Michigan Technological University hope to reduce that timeframe down to minutes.
A collaborative team of chemists and engineers from Michigan Tech lays the groundwork for this vision in two new papers. In the Royal Society of Chemistry’s journal Chemical Communication (DOI: 10.1039/c7cc09809j), the team explains the basic science behind multicolor probes that enable targeting of a cancer-relevant fructose transporter, delving into the image-based detection of cancer cells. In the journal Biosensors (DOI: 10.3390/bios8020039), the team addresses applications for breast cancer detection and differentiating nonmalignant, pre-malignant and malignant cancer cells.
GLUT5 transports fructose and cancer loves sugar
Two Michigan Tech researchers collaborated on the studies. Marina Tanasova, assistant professor of chemistry, and Smitha Rao, assistant professor of biomedical engineering, turned a 10-minute office meeting into a two-year collaboration built on a tiny fluorescent probe that seeks out the fructose transporter named GLUT5.
Cells need carbohydrates; facilitative glucose transporters (GLUTs) bring nutrients in and out of cells. When metabolic swings kick in—say, from cancer development—the overall make-up of GLUTs change so that more or less GLUTs are active. Fructose transporters like GLUT5 are of particular interest because of the direct connection between fructose uptake and cancer development, which also changes as cancer progresses and becomes malignant.
In their Chemical Communications paper, Tanasova and Rao’s team report on the design and validation of the fluorescent probes, called ManCous, to observe GLUT5 activity in a cell. They document the multicolored fluorescence that distinguishes GLUT5-rich cells from those deficient in GLUT5. The follow up Biosensors paper provides a proof-of-principle use of these probes as tools to assess and compare GLUT5 and metabolic activity of different cell types, including normal cells and different cancer subtypes.
“We came closer to a basic screening of cells’ GLUT composition—one that both detects cancer and distinguishes type,” Tanasova says, adding that while the concept is elegant, developing the technology is not easy. “From basic science to application, there is a lot of transformation that has to happen.”
Engineering better cancer detection takes collaboration
By better understanding the science behind sugar transporters, the team is more equipped to build technology that captures an accurate and precise GLUT fingerprint of cancerous cells.
“This probe is like a Swiss army knife,” Rao says, explaining that cancer detection is not the only use for the probe. “The more we learn about cancer through these probes, the more opportunities we have to apply them—which means more chances to treat different cancers, hopefully cure them, and at least prevent their spread and maximize drug delivery.”
What makes the probe so versatile is its ability to not only seek out and highlight cancer cells, but also to reveal the metabolic nuances of different stages of cancer development. While cancer generally gobbles up fructose, the GLUT5 and metabolic activity of nonmalignant, pre-malignant and malignant breast cancer cells do vary, which is what Rao, Tanasova and their team explored in the Biosensors paper. They found that ManCou probes allow for parallel analysis and quantification of GLUT5 and metabolic activity of cells just after a 10-minute incubation period. The notable differences in fluorescence intensity observed between normal cells and cancer cells, as well as different cancer types, provide important points of differentiation between different cell types and make these probes promising tools for cancer detection and diagnostics.
The Latest on: Cancer fingerprint
via Google News
The Latest on: Cancer fingerprint
- Prestigious MacArthur Foundation Fellows include UT Austin's inventor of 'cancer pen' on October 4, 2018 at 11:21 am
Using machine learning, they have discovered unique fingerprints for these types of cancers ... Innovation Award at this year's South by Southwest Conference. A fictional cancer-detecting pen based on ... […]
- UT professor wins MacArthur Foundation Fellowship for work on 'Cancer Pen' on October 4, 2018 at 11:14 am
AUSTIN — Known for her work in helping create a device that helps doctors identify cancer in patients ... The team has discovered unique fingerprint for specific types of cancers, which in turn may he... […]
- Skin cancer test trials start in Australia on October 4, 2018 at 7:23 am
The non-invasive blood test, Melaseq, is designed to detect the genetic fingerprint of active melanoma, a cancer which affects two million Aussies in their lifetime. However those at risk of the ... […]
- Breast cancer campaigners in Saudi Arabia to focus on genetic screening on October 2, 2018 at 7:51 pm
His wife died a month ago. The Saudi Cancer Society has launched its “Pink Fingerprints” awareness campaign to combat breast cancer for a 12th consecutive year. The campaign, which will run throughout ... […]
- Saudi Cancer Society launches ‘Pink Fingerprints’ awareness campaign on October 1, 2018 at 2:06 pm
RIYADH: The Saudi Cancer Society launched an awareness campaign on Monday to combat breast cancer under the name “Pink Fingerprints,” and through the Abdul Latif Jameel Center for Breast Cancer Early ... […]
- Precision Therapeutics Harnesses Artificial Intelligence to Help Discover the Next Generation of Personalized Cancer Therapies on October 1, 2018 at 7:15 am
"By comparing the data 'fingerprint' of the patient's tumor with ... use it to help guide treatment options for a wide range of cancer patients. Meanwhile, it's also in the forefront of using ... […]
- DNA test beats microscopes for predicting cancer’s comeback on September 25, 2018 at 10:12 am
Mutations found before the transplant established a genetic “fingerprint” of each patient’s cancer. About one month after a stem cell transplant, the researchers sequenced each patient’s blood cells a... […]
- The DNA detectives who are hunting the causes of cancer on September 25, 2018 at 4:19 am
The melanoma and lung cancer genomes were powerful proof that the fingerprints of specific culprits could be seen in cancers with one major cause. Yet these tumours still contained many mutations ... […]
- Exclusive: With more immigrant children in detention, HHS cuts funds for other programs — like cancer research on September 19, 2018 at 6:17 pm
The rest is being taken from other programs, including $16.7 million from Head Start, $5.7 million from the Ryan White HIV/AIDS program and $13.3 million from the National Cancer Institute ... inform ... […]
via Bing News